Eden Research plc announces that is has received a Supplementary Protection Certificate from the Patent Office in Greece for its 3AEY plant protection product.
 
A Supplementary Protection Certificate extends the duration of a patent in relation to a specific product. In Eden's case, this means a five-year extension to the patent protection for Eden's fungicide product, 3AEY, which has now been extended in Greece until May 2030. 3AEY is protected under Patent No. 3082101, entitled: "Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them."
 
Eden supplies 3AEY to its partner in Greece, K&N Efthymiadis, who then distributes the product (marketed as 'Mevalone') to its customers.  3AEY is also marketed in Italy as '3logy', in Spain as 'ARAW', in Kenya as 'Hawk' and will be sold in France from this year as 'Mevalone'.
 
Sean Smith, Chief Executive Officer of Eden, said: "Intellectual property is a critical element for Eden's success and value creation.  A five-year extension for the patent which covers our first product is valuable to both us and our partners.
 
"This is the first of several applications for Supplementary Protection Certificates in key territories.  As part of the Company's ongoing intellectual property lifecycle management, we are pursing the extension of patented rights in key markets globally."